These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29358842)

  • 1. Elevated Level of Troponin but Not N-Terminal Probrain Natriuretic Peptide Is Associated with Increased Risk of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Calculated According to the ESC Guidelines 2014.
    Rajtar-Salwa R; Hładij R; Dimitrow PP
    Dis Markers; 2017; 2017():9417908. PubMed ID: 29358842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Troponin as ischemic biomarker is related with all three echocardiographic risk factors for sudden death in hypertrophic cardiomyopathy (ESC Guidelines 2014).
    Hładij R; Rajtar-Salwa R; Dimitrow PP
    Cardiovasc Ultrasound; 2017 Sep; 15(1):24. PubMed ID: 28903763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal pro-brain natriuretic peptide and sudden cardiac death in hypertrophic cardiomyopathy.
    Wu G; Liu J; Wang S; Yu S; Zhang C; Wang D; Zhang M; Yang Y; Kang L; Zhao S; Hui R; Zou Y; Wang J; Song L
    Heart; 2021 Oct; 107(19):1576-1583. PubMed ID: 33361398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitivity cardiac troponin I and NT-proBNP as predictors of incident dementia and Alzheimer's disease: the FINRISK Study.
    Tynkkynen J; Hernesniemi JA; Laatikainen T; Havulinna AS; Salo P; Blankenberg S; Zeller T; Salomaa V
    J Neurol; 2017 Mar; 264(3):503-511. PubMed ID: 28039523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.
    Gawor M; Śpiewak M; Janas J; Kożuch K; Wróbel A; Mazurkiewicz Ł; Baranowski R; Marczak M; Grzybowski J
    Kardiol Pol; 2017; 75(10):997-1004. PubMed ID: 28612913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic Cardiomyopathy: The Time-Synchronized Relationship between Ischemia and Left Ventricular Dysfunction Assessed by Highly Sensitive Troponin I and NT-proBNP.
    Rajtar-Salwa R; Gębka A; Dziewierz A; Dimitrow PP
    Dis Markers; 2019; 2019():6487152. PubMed ID: 31320942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversed Septal Curvature Is Associated with Elevated Troponin Level in Hypertrophic Cardiomyopathy.
    Rajtar-Salwa R; Tokarek T; Dimitrow PP
    Dis Markers; 2020; 2020():8821961. PubMed ID: 33354249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of serum cardiac biomarkers for right ventricular dysfunction in non-high-risk patients with acute pulmonary thromboembolism].
    Liu FF; Gong JN; Jiang Y; Kuang TG; Yang YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Nov; 41(11):847-852. PubMed ID: 30423626
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictive Values of N-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin I for Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy.
    Zhang C; Liu R; Yuan J; Cui J; Hu F; Yang W; Zhang Y; Chen Y; Qiao S
    PLoS One; 2016; 11(1):e0146572. PubMed ID: 26765106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Sudden Cardiac Death in Doberman Pinschers with Dilated Cardiomyopathy.
    Klüser L; Holler PJ; Simak J; Tater G; Smets P; Rügamer D; Küchenhoff H; Wess G
    J Vet Intern Med; 2016 May; 30(3):722-32. PubMed ID: 27177626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-type natriuretic peptide and risk of sudden death in patients with hypertrophic cardiomyopathy.
    Minami Y; Haruki S; Kanbayashi K; Maeda R; Itani R; Hagiwara N
    Heart Rhythm; 2018 Oct; 15(10):1484-1490. PubMed ID: 29709578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy.
    Arteaga E; Araujo AQ; Buck P; Ianni BM; Rabello R; Mady C
    Am Heart J; 2005 Dec; 150(6):1228-32. PubMed ID: 16338263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach: the North Wuerttemberg and Berlin Infarction Study-II (NOBIS-II).
    Möckel M; Müller R; Vollert J; Müller C; Danne O; Gareis R; Störk T; Dietz R; Koenig W
    Clin Res Cardiol; 2007 Sep; 96(9):604-12. PubMed ID: 17593313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of cardiovascular injury and stress are associated with increased frequency of ventricular ectopy: a population-based study.
    Skranes JB; Einvik G; Namtvedt SK; Randby A; Hrubos-Strøm H; Brynildsen J; Hagve TA; Somers VK; Røsjø H; Omland T
    BMC Cardiovasc Disord; 2016 Nov; 16(1):233. PubMed ID: 27875987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive troponin and N-terminal probrain natriuretic peptide in stable angina.
    Ndrepepa G; Braun S; Schulz S; Fusaro M; Keta D; Pache J; Seyfarth M; Mehilli J; Schömig A; Kastrati A
    Eur J Clin Invest; 2011 Oct; 41(10):1054-62. PubMed ID: 21413976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-sensitivity troponin I in persistent atrial fibrillation - relation to NT-proBNP and markers of inflammation and haemostasis.
    Horjen AW; Ulimoen SR; Norseth J; Svendsen JH; Smith P; Arnesen H; Seljeflot I; Tveit A
    Scand J Clin Lab Invest; 2018 Sep; 78(5):386-392. PubMed ID: 29933716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between P wave dispersion, atrial electromechanical delay, left atrial remodeling, and NT-proBNP levels, in patients with hypertrophic cardiomyopathy.
    Tuluce K; Ozerkan F; Yakar Tuluce S; Yavuzgil O; Gurgun C; Bilgin M; Kahya Eren N; Kocabas U; Nalbantgil S; Soydas Cinar C
    Cardiol J; 2015; 22(1):94-100. PubMed ID: 24671901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Future Atrial Fibrillation Development in Patients with Hypertrophic Cardiomyopathy: A Prospective Follow-Up Study.
    Tuluce K; Yakar Tuluce S; Kahya Eren N; Kocabas U; Akyildiz Akcay F; Gunduz R; Akyildiz ZI; Ergene O
    Echocardiography; 2016 Mar; 33(3):379-85. PubMed ID: 26493159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of atenolol on NT-proBNP and troponin in asymptomatic cats with severe left ventricular hypertrophy because of hypertrophic cardiomyopathy: a pilot study.
    Jung SW; Kittleson MD
    J Vet Intern Med; 2011; 25(5):1044-9. PubMed ID: 21781160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathy.
    D'Amato R; Tomberli B; Castelli G; Spoladore R; Girolami F; Fornaro A; Caldini A; Torricelli F; Camici P; Gensini GF; Cecchi F; Olivotto I
    Am J Cardiol; 2013 Oct; 112(8):1190-6. PubMed ID: 23871673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.